Meropenem

CAS No. 96036-03-2

Meropenem( ICI 194660 | Merrem I.V. | SM-7338 )

Catalog No. M16855 CAS No. 96036-03-2

Meropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 38 In Stock
100MG 52 In Stock
200MG 73 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Meropenem
  • Note
    Research use only, not for human use.
  • Brief Description
    Meropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria.
  • Description
    Meropenem is a broad-spectrum carbapenem antibiotic. It is active against Gram-positive and Gram-negative bacteria. Meropenem exerts its action by penetrating bacterial cells readily and interfering with the synthesis of vital cell wall components, which leads to cell death. (In Vitro):Meropenem is intrinsically stable to dehydropeptidase-1 (DHP-1) degradation and Meropenem acts by inhibiting bacterial cell wall synthesis by binding to and inactivating penicillin-binding proteins (PBPs). Meropenem possesses broad-spectrum in vitro activity, which includes activity against many Gram-positive, Gram-negative and anaerobic bacteria; Meropenem lacks activity against Enterococcus faecium, methicillin-resistant Staphylococcus aureus and Stenotrophomonas maltophilia.(In Vivo):Meropenem (60 mg/kg; intraperitoneal injection; once; SD rats) treatment significantly reduces the incidence of pancreatic infection.
  • In Vitro
    Meropenem is intrinsically stable to dehydropeptidase-1 (DHP-1) degradation and Meropenem acts by inhibiting bacterial cell wall synthesis by binding to and inactivating penicillin-binding proteins (PBPs). Meropenem possesses broad-spectrum in vitro activity, which includes activity against many Gram-positive, Gram-negative and anaerobic bacteria; Meropenem lacks activity against Enterococcus faecium, methicillin-resistant Staphylococcus aureus and Stenotrophomonas maltophilia.
  • In Vivo
    Meropenem (60 mg/kg; intraperitoneal injection; once; SD rats) treatment significantly reduces the incidence of pancreatic infection. Animal Model:Male Sprague-Dawley rats (250-350 g) induced acute necrotizing pancreatitis Dosage:60 mg/kg Administration:Intraperitoneal injection; once Result:Significantly reduced the incidence of pancreatic infection.
  • Synonyms
    ICI 194660 | Merrem I.V. | SM-7338
  • Pathway
    Microbiology/Virology
  • Target
    Antibiotic
  • Recptor
    β-Lactamase| D-alanyl-D-alanine carboxypeptidase DacB
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    96036-03-2
  • Formula Weight
    383.46
  • Molecular Formula
    C17H25N3O5S
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 8 mg/mL (20.86 mM); DMSO: 77 mg/mL (200.8 mM)
  • SMILES
    O=C(C(N12)=C(S[C@@H]3CN[C@H](C(N(C)C)=O)C3)[C@H](C)[C@]2([H])[C@@H]([C@H](O)C)C1=O)O
  • Chemical Name
    (4R,5S,6S)-3-(((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl)thio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Edwards JR, et al. J Antimicrob Chemother, 1995, 36 Suppl A, 1-17.
molnova catalog
related products
  • 5-Hydroxyuridine

    5-Hydroxyuridine (OHUrd) is a purine nucleoside analogue with potential antitumor activity, demonstrating cytotoxicity against human colon adenocarcinoma cell lines.

  • Moxipraquine

    Moxipraquine is a novel 8-aminoquinolone compound with anti-infective activity against Trypanosoma cruzi. Moxipraquine effectively inhibited parasitemia but did not eradicate infections in mice or guinea pigs.

  • Chitin synthase inhi...

    Chitin synthase inhibitor 4 is a chitin synthase (CHS) inhibitor with antimicrobial activity.Chitin synthase inhibitor 4 is a CHS-based compound and a candidate fungicide.